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Abstract. Existing approaches to modeling the dynamics of brain tumor
growth, specifically glioma, employ biologically inspired models of cell
diffusion, using image data to estimate the associated parameters. In this
work, we propose an alternative approach based on recent advances in
probabilistic segmentation and representation learning that implicitly
learns growth dynamics directly from data without an underlying ex-
plicit model. We present evidence that our approach is able to learn a
distribution of plausible future tumor appearances conditioned on past
observations of the same tumor.
Keywords: Glioma Growth · Generative Modeling · Probabilistic Seg-
mentation
1 Introduction
Glial tumors, especially high grade ones known as glioblastoma multiforme
(GBM), are associated with highly irregular growth patterns, involving multiple
tissue types for which the change in composition is notoriously difficult to predict.
While the prognosis for patients is generally poor, with a median survival of
15-16 months given standard of care treatment for GBM, a considerable number
of patients with high grade glioma survive multiple years after diagnosis [2]. An
important factor for this is radiotherapy, which could benefit greatly from a
better understanding of growth dynamics.
Most existing approaches that model the growth of glioma do this using
variants of the reaction-diffusion equation on the basis of DTI data, e.g. [3,11],
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but also multi-modal data [10,7], a very recent example being [6] (for works from
before 2011 we refer the reader to [9]).
In this work, we propose to learn growth dynamics directly from annotated MR
image data, without specifying an explicit model, leveraging recent developments
in deep generative models [5]. We further assume that imaging is ambiguous with
respect to the underlying disease (an assumption shared e.g. in [10,6]), which is
reflected in our approach in that it doesn’t predict a single growth estimate (as
is done e.g in [1,13] on a per-pixel level) but instead estimates a distribution of
plausible changes for a given tumor. In plain words, we’re not interested in the
question “How much will the tumor grow (or shrink)?” but instead “If the tumor
were to grow (or shrink), what would it look like?”. From a clinical perspective,
this is relevant for example in radiation therapy, where a margin of possible
infiltration around the tumor will also be irradiated. This is currently done in
a rather crude fashion by isotropically expanding the tumor’s outline [8], thus
more informed estimates of growth patterns could help spare healthy tissue. Our
contributions are the following:
– We frame tumor growth modeling as a model-free learning problem, so that
all dynamics are inferred directly from data.
– We present evidence that our approach learns a distribution of plausible
growth trajectories, conditioned on previous observations of the same tumor.
– We provide source code: https://github.com/jenspetersen/probabilistic-unet.
2 Methods
The underlying hypothesis of our approach is that tumor growth is at least in part
stochastic so that it’s not possible to predict a single correct growth trajectory in
time from image data alone. Hence, our aim is to model a distribution of possible
changes of a tumor given the current and in our case one previous observation.
We achieve this by training a model to reproduce true samples of observed growth
trajectories—with shape and extent of the tumor being represented as multi-
class segmentation maps—and using variational inference to allow the model to
automatically recognize and account for ambiguity in the task.
2.1 Data
We work with an in-house dataset containing a total of 199 longitudinal MRI
scans from 38 patients suffering from glioma (15 lower grade glioma and 23
glioblastoma), with a median of 96 days between scans and 5 scans per patient.
Patients have undergone different forms of treatment, a fact that we deliberately
neglect by declaring it an additional source of ambiguity in the dataset. Each
scan consists of 4 contrasts: native T1 (T1n), postcontrast T1 (T1ce), T2 (T2)
and fluid-attenuated inversion recovery (FLAIR). All contrasts and time steps
for a given patient are skull-stripped, registered to T1 space and resampled to
isotropic 1mm resolution [4]. For intensity normalization, we only employ basic
z-score normalization. Ground truth segmentations of edema, enhancing tumor
and necrosis were created semi-automatically by an expert radiologist.
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2.2 Model
Our model along with the training procedure, based on a probabilistic segmen-
tation approach [5], are visualized in fig. 1. The architecture comprises three
components: 1. A U-Net [12] to map scans from present and past to future tumor
appearance. 2. A fully convolutional encoder that maps scans from present and
past to an N -dimensional diagonal Gaussian (the prior ; we choose N = 3). 3.
An encoder with the same architecture that maps scans from present and past as
well as the ground truth segmentation from the future to another diagonal Gaus-
sian (the posterior ; N = 3). During training we sample from the posterior and
concatenate the sample to the activations of the last decoder block in the U-Net,
so as to condition the softmax predictions on the sample. We employ multi-class
cross entropy as the segmentation loss and use the Kullback-Leiber divergence
to force prior and posterior towards each other, so that at test time—when a
ground truth segmentation is no longer available—the predicted prior is as close
as possible to the unknown posterior. This objective is the well known evidence
lower bound used in variational inference.
The described training scheme will give rise to the following desirable proper-
ties: 1) The model will learn to represent the task’s intrinsic ambiguity in the
Gaussian latent space, in our case different plausible future tumor shapes and
sizes, as we show in section 3. 2) At test time we can sample multiple consistent
hypotheses from the latent space (as seen in fig. 2), and select those that match
desired criteria (e.g. tumor volume increases by 20%).
We train with data augmentation (using https://github.com/MIC-DKFZ/
batchgenerators) on patches of size 1123, but evaluate on full sized scans of
1923. For details on optimization and associated hyperparameters we refer to the
provided source code (https://github.com/jenspetersen/probabilistic-unet).
2.3 Experiments & Evaluation
We seek to show that our approach learns meaningful future tumor appearances
instead of just segmentation variants of the present input. For this reason we
construct a baseline that is restricted to learning the latter.
Let A denote past, B present and C future. Our model is trained and evaluated
for triples AB → C (that we will refer to as cases), as shown in fig. 1. An upper
bound on performance is given by a regular probabilistic segmentation model
that is trained and evaluated with tuples C → C. This is essentially a model that
has complete knowledge of the future and just needs to segment it. At the same
time, a model trained on B → B but evaluated on B → C can serve as a lower
bound to our model trained on AB → C. If our performance matches that of the
lower bound, we have learned to produce plausible segmentations for the current
time step, but not the future.
We split our subjects randomly into 5 groups and perform 5-fold cross valida-
tion, i.e. we train on 4 subsets and predict the remaining one. For many triples,
the real change between time steps is small, which makes it hard to show that
our approach actually learns meaningful change. As a consequence we define two
groups to report results for:
4 J. Petersen et al.
KL CE
Prior Encoder
Posterior Encoder
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Loss 2x (Conv + InstanceNorm + LeakyReLU)
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Sample
Fig. 1. The architecture employed in this work. Following the approach in [5], a U-
Net [12] is augmented with two additional encoders, one for the prior and one for
the posterior. The prior encoder maps the inputs of present and past scans to an
N -dimensional diagonal Gaussian while the posterior does the same with additional
access to the ground truth segmentation from the future. During training, a sample
from the posterior is injected into the U-Net after the last decoder block to produce an
output that is conditioned on the posterior. During testing the posterior is unavailable
and samples can only be drawn from the prior. A KL divergence loss is used to force
prior and posterior towards each other while cross entropy is used as segmentation loss.
Dashed lines indicate paths that only apply during training.
1. Large Change: The 10% of cases with the most pronounced change in terms
of whole tumor Dice overlap, resulting in a threshold of 0.48 and 13 cases.
2. Moderate Change The cases with larger than mean change (0.70), but not
in top 10%, resulting in 44 cases.
We are not interested in predictive capabilities, so it makes little sense to
look at the overlap of the prior mean predictions with the future ground truth
(our approach performs not much better than the lower bound here). We report
metrics that are representative of our model’s desired capabilities, 1) a clinically
relevant question, i.e. what the tumor will look like for a given expected size, and
2) how well the model is able to represent large changes in its latent space:
1. Query Volume Dice: We take samples from a grid around the prior mean
(−3σ to +3σ in steps of 1σ) and select the segmentation for which the whole
tumor volume (i.e. all tumor classes contribute) best matches that of the
ground truth. If our approach is able to model future appearances, it should
perform better than the lower bound with increasing real change.
2. Surprise: This is the KL divergence the model assigns for a given combination
of past & present scans and future ground truth. A lower KL divergence
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between prior and posterior means the model deems the combination more
realistic, i.e. it is less surprised.
3 Results
3.1 Qualitative Results
We first present several qualitative examples, selected to illustrate the types of
changes our approach is able to represent.
Figure 2 a) shows three cases with outlines for the prior mean (solid purple)
prediction as well as the sample from the prior (dotted purple) that best matches
the volume of the real future (red). The similarity of the latter two in the
first two columns indicates that our model is able to represent both strong
growth and strong reduction in size well. It can also be seen that the mean
prediction closely matches the current state of the tumor, which is unsurprising,
because small changes occur most frequently. The third column is illustrative
of a general limitation of our model: encoding into the latent space removes all
spatial resolution, so tumors that both shrink and grow in different locations (e.g.
with multiple foci) are not represented in the current setup.
Figure 2 b) illustrates how the learned latent space represents semantically
meaningful continuous variations: Dimension 2 changes the size of just the
enhancing tumor while dimension 1 changes the size of the tumor core (enhancing
tumor and necrosis combined). The third axis that is not shown encodes variation
in the size of the edema, meaning that the model automatically learned to separate
the contributions of the different tumor regions. Most importantly, all variations
seem plausible. Note that while a reduction in necrosis is biologically implausible
in a treatment-naive context, it might very well occur under treatment like in
our dataset.
3.2 Quantitative Results
In this section we compare our approach with an upper bound and a lower bound.
These are given by a regular probabilistic U-Net [5] trained for segmentation
with (upper bound) and without (lower bound) knowledge of the future and both
evaluated with respect to future ground truth.
Figure 3 shows median results for two different metrics and both moderate
change and large change. Query Volume Dice represents the clinically motivated
question of estimating spatial extent for a given change in size (e.g. for radiation
therapy). Particularly for cases with large change our approach outperforms the
lower bound. At the same time, the Surprise, a measure of how close estimated
prior and posterior are for a given set of inputs and future ground truth, is
on par with the upper bound for cases with moderate change and still much
lower than the lower bound’s for large change cases. For reference, in VAEs this
usually comes at the cost of poor reconstruction, but the reconstruction loss
(i.e. segmentation cross entropy, not shown) is also much lower for our approach
compared to the lower bound in both cases.
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Fig. 2. Qualitative Examples: (a) Prior mean prediction (solid purple) and sample with
best volume match (dashed purple) as well as future ground truth (red) overlaid on
FLAIR. The approach is able to model growth or shrinkage, but is unable to represent
tumors with both growth and shrinkage in different locations (for multiple foci, dotted
and solid overlap). (b) Regular grid samples from prior, with mean highlighted in red
and ground truth inlay in bottom left corner (unrelated to (a)). The learned latent space
separates class contributions, dimension 1 seems to encode tumor core size (enhancing
tumor and necrosis) while dimension 2 encodes enhancing tumor size (note how necrosis
is virtually constant in the top row). The third latent dimension, not shown here,
captures small variations in edema size. Purple – Edema, Orange – Enhancing Tumor,
Yellow – Necrosis
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Fig. 3. Quantitative results for Query Volume Dice and Surprise, for groups with
moderate and large change and median indicated in red, p-values from Wilcoxon rank-
sum test. For large changes, our approach can represent the future much better than
the lower bound. The low surprise in our model indicates that our model’s learned prior
assigns higher likelihood than the lower bound to the real future tumor appearance,
leveraging temporal information from previous scans.
4 Discussion
In this work we investigated whether glioma growth dynamics can be learned
directly from data without an underlying explicit biological model, instead relying
on probabilistic segmentation to model distributions of future tumor appearances.
Our results indicate that this is indeed possible. We showed quantitatively
that our approach can represent large variations in the inferred distributions
and that these learned distributions model growth trajectories instead of just
segmentation variants for a known input. Qualitative examples show overall
realistic growth as well as shrinkage patterns. Compared to existing work, our
approach relies on a very different hypothesis, so we elected to present metrics
that evaluate our desired goals, but are unfortunately unsuitable for quantitative
comparison with classical methods.
Our work has a number of shortcomings we’d like to explicitly address. While
our dataset is larger than what is usually presented in the literature on glioma
growth, our method clearly requires more data than existing ones that are based
on explicit biological diffusion models. Without a doubt the dataset is too small
to be representative of all plausible growth variations. We were also unable to
apply our approach on more than two input time steps, because this reduced
the amount of available training instances too drastically. As we pointed out,
our model is also unable (and not designed) to predict a single correct growth
trajectory. It is further unable to resolve spatially varying growth for a single
tumor, likely because we employ a simple global latent space. On the other
hand, more complex models would again require more data. Finally, it would be
desirable to represent time continuously instead of working with discrete steps.
Contrasting the above, we also see some advantages that our approach offers.
The ability to sample consistent hypotheses from the latent space, as opposed to
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just having pixel-wise probability estimates, lends itself to answering clinically
motivated questions, e.g. exploring only samples that correspond to strong growth
or those that produce predictions where a certain region is or is not affected by
the tumor. We further don’t rely on imaging modalities like DTI that are not
typically acquired in clinical routine. It would in fact be interesting to explore if
our approach can benefit from including the latter.
Overall we feel our work opens up a promising new avenue of approaching
glioma growth and tumor growth in general. We are confident that much larger
datasets will become available in the future that will allow our method to further
improve. Most importantly, our work is entirely complementary with respect to
diffusion-based models, and combining them should be exciting to explore.
References
1. Akbari, H., Macyszyn, L., Da, X., Bilello, M., Wolf, R.L., Martinez-Lage, M., Biros,
G., Alonso-Basanta, M., O’Rourke, D.M., Davatzikos, C.: Imaging surrogates of in-
filtration obtained via multiparametric imaging pattern analysis predict subsequent
location of recurrence of glioblastoma. Neurosurgery 78(4), 572–580 (2016)
2. Bi, W.L., Beroukhim, R.: Beating the odds: extreme long-term survival with
glioblastoma. Neuro-Oncology 16(9), 1159–1160 (2014)
3. Engwer, C., Hillen, T., Knappitsch, M., Surulescu, C.: Glioma follow white matter
tracts: a multiscale DTI-based model. Journal of Mathematical Biology 71(3),
551–582 (2015)
4. Jenkinson, M., Beckmann, C.F., Behrens, T.E.J., Woolrich, M.W., Smith, S.M.:
FSL. NeuroImage 62(2), 782–790 (2012)
5. Kohl, S.A.A., Romera-Paredes, B., Meyer, C., De Fauw, J., Ledsam, J.R., Maier-
Hein, K.H., Eslami, S.M.A., Jimenez Rezende, D., Ronneberger, O.: A probabilistic
u-net for segmentation of ambiguous images. In: NeurIPS. vol. 31 (2018)
6. Lipkova, J., Angelikopoulos, P., Wu, S., Alberts, E., Wiestler, B., Diehl, C., Preibisch,
C., Pyka, T., Combs, S., Hadjidoukas, P., Van Leemput, K., Koumoutsakos, P.,
Lowengrub, J.S., Menze, B.: Personalized radiotherapy design for glioblastoma:
Integrating mathematical tumor models, multimodal scans and bayesian inference.
IEEE Transactions on Medical Imaging preprint pp. 1–1 (2019)
7. Lê, M., Delingette, H., Kalpathy-Cramer, J., Gerstner, E.R., Batchelor, T., Unkel-
bach, J., Ayache, N.: Personalized radiotherapy planning based on a computational
tumor growth model. IEEE Transactions on Medical Imaging 36(3), 815–825 (2017)
8. Mann, J., Ramakrishna, R., Magge, R., Wernicke, A.G.: Advances in radiotherapy
for glioblastoma. Frontiers in Neurology 8 (2018)
9. Menze, B.H., Stretton, E., Konukoglu, E., Ayache, N.: Image-based modeling of
tumor growth in patients with glioma. In: Optimal Control in Image Processing,
p. 12 (2011)
10. Menze, B.H., Van Leemput, K., Honkela, A., Konukoglu, E., Weber, M.A., Ayache,
N., Golland, P.: A generative approach for image-based modeling of tumor growth.
Information Processing in Medical Imaging 22, 735–747 (2011)
11. Mosayebi, P., Cobzas, D., Murtha, A., Jagersand, M.: Tumor invasion margin on
the riemannian space of brain fibers. Medical Image Analysis 16(2), 361–373 (2012)
12. Ronneberger, O., Fischer, P., Brox, T.: U-net: Convolutional networks for biomedical
image segmentation. In: Proc. MICCAI. pp. 234–241 (2015)
Deep Probabilistic Modeling of Glioma Growth 9
13. Zhang, L., Lu, L., Summers, R.M., Kebebew, E., Yao, J.: Convolutional invasion
and expansion networks for tumor growth prediction. IEEE Transactions on Medical
Imaging 37(2), 638–648 (2018)
